In relation to AD, miRNA-98-5p has been demonstrated to inhibit the expression of the α7 nicotinic acetylcholine receptor (nAChR), a receptor vital for cognitive function and the regulation of neuroinflammation. The gene discussed is CHRNA7; the disease is Alzheimer disease.